|
⚲
|
| Keyboard |
| Mazur Leonard L
✚
|
|
|---|---|
| CIK # | 0001463414 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001463414] | |
| 4 | [0001463414] | |
| SC 13D | [0001463414] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Mazur Leonard L | Citius Pharmaceuticals Inc | [2018-08-27] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Citius Oncology Inc | |
| Mazur Leonard L | |
| Citius Pharmaceuticals Inc | |
| Canton Strategic Holdings Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
|
2024-12-12 | Grant | 800,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Stock Option (Right to Purchase Common Stock) · derivative
|
2024-11-07 | Grant | 600,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Warrant to Purchase Common Stock · derivative
|
2024-09-25 | Disposed to issuer | 2,234,700 | ||
|
Citius Pharmaceuticals Inc CTXR
Warrant to Purchase Common Stock · derivative
|
2024-09-25 | Grant | 2,234,700 | ||
|
Citius Pharmaceuticals Inc CTXR
Warrant to Purchase Common Stock · derivative
|
2024-08-14 | Grant | 3,137,255 | ||
|
Citius Pharmaceuticals Inc CTXR
Warrant to Purchase Common Stock · derivative
|
2024-08-14 | Disposed to issuer | 3,137,255 | ||
|
Citius Oncology Inc CTOR
Stock Option (Right to Buy) · derivative
|
2024-08-12 | Grant | 1,233,333 | $0.00 | |
|
Canton Strategic Holdings Inc THAR
Options (right to buy) · derivative
|
2024-08-09 | Grant | 2,353 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Warrant to Purchase Common Stock · derivative
|
2024-04-03 | Disposed to issuer | 1,165,048 | ||
|
Citius Pharmaceuticals Inc CTXR
Warrant to Purchase Common Stock · derivative
|
2024-04-03 | Grant | 1,165,048 | ||
|
Canton Strategic Holdings Inc THAR
Options (right to buy) · derivative
|
2023-11-07 | Grant | 25,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Option to Purchase Common Stock · derivative
|
2023-10-10 | Grant | 550,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Option to Purchase Common Stock · derivative
|
2022-10-04 | Grant | 550,000 | $0.00 | |
|
Canton Strategic Holdings Inc HILS
Options (right to buy) · derivative
|
2022-03-21 | Grant | 50,000 | $0.00 | |
|
Canton Strategic Holdings Inc HILS
Common Stock
|
2022-01-14 | Conversion | 98,733 | $3.20 | 315,946 |
|
Canton Strategic Holdings Inc HILS
Common Stock
|
2022-01-14 | Buy | 25,000 | $4.00 | 100,000 |
|
Canton Strategic Holdings Inc HILS
Convertible Note · derivative
|
2022-01-14 | Conversion | $0.00 | ||
|
Citius Pharmaceuticals Inc CTXR
Option to Purchase Common Stock · derivative
|
2021-10-11 | Grant | 650,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Options to Purchase Common Stock · derivative
|
2021-07-22 | Grant | 300,000 | $0.00 | |
|
Citius Pharmaceuticals Inc CTXR
Options to Purchase Common Stock · derivative
|
2020-10-06 | Grant | 200,000 | $0.00 | |
| showing 20 of 50 most recent transactions | |||||